Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Prepaid Assets (2023 - 2025)

Historic Prepaid Assets for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to $7.3 million.

  • Immunome's Prepaid Assets rose 8631.71% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 8631.71%. This contributed to the annual value of $4.0 million for FY2024, which is 3848.5% down from last year.
  • Latest data reveals that Immunome reported Prepaid Assets of $7.3 million as of Q3 2025, which was up 8631.71% from $9.4 million recorded in Q2 2025.
  • Over the past 5 years, Immunome's Prepaid Assets peaked at $9.4 million during Q2 2025, and registered a low of $773000.0 during Q3 2023.
  • Its 3-year average for Prepaid Assets is $4.6 million, with a median of $4.0 million in 2024.
  • Within the past 5 years, the most significant YoY rise in Immunome's Prepaid Assets was 43432.43% (2024), while the steepest drop was 3848.5% (2024).
  • Over the past 3 years, Immunome's Prepaid Assets (Quarter) stood at $6.6 million in 2023, then crashed by 38.48% to $4.0 million in 2024, then soared by 80.5% to $7.3 million in 2025.
  • Its Prepaid Assets stands at $7.3 million for Q3 2025, versus $9.4 million for Q2 2025 and $5.8 million for Q1 2025.